Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | TP53 | P04637 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 0.82 |
| ▸ | ESR1 | P03372 | 5/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.82 |
| ▸ | PGR | P06401 | 2/20 | 0.82 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.82 |
| ▸ | AR | P10275 | 2/20 | 0.82 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.82 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.82 |
| ▸ | POLB | P06746 | 1/20 | 0.82 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.82 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.82 |
| ▸ | ATM | Q13315 | 1/20 | 0.82 |
| ▸ | USP2 | O75604 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Estradiol Propionate SCHEMBL26659949 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL480992 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL30384276 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL28094685 | 0.98 | MAPT (0.96) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL28092621 | 0.95 | MAPT (0.91) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL27583398 | 0.93 | MAPT (0.86) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL9404746 | 0.92 | MAPT (0.89) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL19393249 | 0.92 | MAPT (0.89) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL822184 | 0.92 | MAPT (0.85) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL19286812 | 0.92 | MAPT (0.85) | MAPTKMT2AMEN1CYP3A4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688003-A2 | LIPOSOMAL COMPOSITIONS OF ARCHEXIN | The Whiteoak Group, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4630562-A1 | NUCLEIC ACID BASED CANCER VACCINE AND METHODS THEREOF | Advanced RNA Vaccine (ARV) Technologies, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4608812-A1 | VITAMIN-BASED LIPIDS AND LIPID NANOPARTICLES COMPRISING THE SAME | Advanced RNA Vaccine (ARV) Technologies, Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4577193-A1 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS | Ohio State Innovation Foundation (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4568645-A2 | STEROL BASED IONIZABLE LIPIDS AND LIPID NANOPARTICLES COMPRISING THE SAME | Advanced RNA Vaccine (ARV) Technologies, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024206077-A2 | DOSING REGIMES AND COMBINATION THERAPIES USING ARCHEXIN FOR THE TREATMENT OF CANCER | THE WHITEOAK GROUP, INC. (US) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024206078-A2 | LIPOSOMAL COMPOSITIONS OF ARCHEXIN | THE WHITEOAK GROUP, INC. (US) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024124232-A1 | NUCLEIC ACID BASED CANCER VACCINE AND METHODS THEREOF | ADVANCED RNA VACCINE (ARV) TECHNOLOGIES, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024092209-A1 | VITAMIN-BASED LIPIDS AND LIPID NANOPARTICLES COMPRISING THE SAME | ADVANCED RNA VACCINE (ARV) TECHNOLOGIES, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2024044370-A1 | COMPOSITIONS AND METHODS FOR THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS | OHIO STATE INNOVATION FOUNDATION (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024035710-A2 | STEROL BASED IONIZABLE LIPIDS AND LIPID NANOPARTICLES COMPRISING THE SAME | ADVANCED RNA VACCINE (ARV) TECHNOLOGIES, INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| WO-2023133560-A2 | TISSUE ENGINEERING AND DRUG DELIVERY DEVICE | OHIO STATE INNOVATION FOUNDATION (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2022271255-A1 | TISSUE-ENGINEERED SCAFFOLDS AND METHODS OF MAKING | GEORGIA TECH RESEARCH CORPORATION (US) | 2022-12-29 | — | — | WO | disclosed |